跳至主要内容
临床试验/NL-OMON33875
NL-OMON33875已完成2 期

Place of Reveal® In the peri-operative aSsessment of patients undergoing Major vascular surgery (PRISM2). - PRISM2

Medtronic Bakken Research Center B.V.0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patient is scheduled for non-cardiac vascular surgery of the for elective aortic abdominal aneurysm repair or lower extremity bypass surgery;
  • Patients eligible for the study are 18 years or older;
  • Patient is willing to receive a Reveal XT insertion and can be implanted with Reveal XT;
  • Patient is willing to wear external Holter devices for a 72 hour period;
  • Patient is willing to give his/her informed consent;

排除标准

  • Patient has an implanted pacemaker or ICD;
  • Patient has an allergy against adhesive surface ECG electrode;
  • The study will interfere with a therapeutic or diagnostic procedure which is planned or expected within the study period;
  • Patient is a minor, legally incompetent, or does not meet other local requirements for participation in a clinical study.
  • Patients has electrocardiographic abnormalities that preclude assessment of cardiac arrhythmias or myocardial ischemia will be excluded.
  • Patient has a changing ST-segment, i.e. a Bundle Branch Block and further ST-segment changes cannot be assessed.
  • Patient is pregnant

研究者

相似试验